Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.08.24 | Actinogen Medical - Further positive XanaCIDD results on depression | 347 | Edison Investment Research | New data were revealed from Actinogen Medical's ongoing analysis of the now-completed XanaCIDD study that support the view that the company's lead drug candidate, Xanamem, may provide consistent and... ► Artikel lesen | |
27.08.24 | Mendus - Broad progress across the pipeline | 248 | Edison Investment Research | Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 2.887 |
NVIDIA | 2.767 |
THYSSENKRUPP | 2.347 |
RENK GROUP | 2.160 |
STEYR MOTORS | 1.941 |
DEUTZ | 1.906 |
BYD | 1.826 |
NEL | 1.807 |
RHEINMETALL | 1.755 |
BAYER | 1.621 |
XIAOMI | 1.461 |
TUI | 1.458 |
NOVO NORDISK | 1.275 |
EVOTEC | 1.164 |
COMMERZBANK | 965 |
VOLKSWAGEN | 866 |
DEUTSCHE BANK | 857 |
MUTARES | 838 |
AIXTRON SE | 807 |
MERCEDES-BENZ | 789 |
NORDEX | 773 |
BASF | 723 |
PORSCHE AG | 716 |
PUMA | 684 |
RWE | 671 |